Literature DB >> 26645510

Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.

W C Hochberger1, S K Hill2, C L M Nelson1, J L Reilly3, R S E Keefe4, G D Pearlson5, M S Keshavan6, C A Tamminga7, B A Clementz8, J A Sweeney7.   

Abstract

Despite robust evidence of neurocognitive dysfunction in psychotic patients, the degree of similarity in cognitive architecture across psychotic disorders and among their respective first-degree relatives is not well delineated. The present study examined the latent factor structure of the Brief Assessment of Cognition in Schizophrenia (BACS) neuropsychological battery. Analyses were conducted on 783 psychosis spectrum probands (schizophrenia, schizoaffective, psychotic bipolar), 887 of their first-degree relatives, and 396 non-psychiatric controls from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. Exploratory factor analysis of BACS subtest scores indicated a single-factor solution that was similar across all groups and provided the best overall data fit in confirmatory analyses. Correlations between the standard BACS composite score and the sum of subscale scores weighted by their loadings on this unitary factor were very high in all groups (r≥.99). Thus, the BACS assesses a similar unitary cognitive construct in probands with different psychotic disorders, in their first-degree relatives, and in healthy controls, and this factor is well measured by the test's standard composite score.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brief Assessment of Cognition in Schizophrenia; Factor analysis; First-degree relatives; Psychosis

Mesh:

Year:  2015        PMID: 26645510      PMCID: PMC5226655          DOI: 10.1016/j.schres.2015.11.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

1.  The MATRICS initiative: developing a consensus cognitive battery for clinical trials.

Authors:  Michael F Green; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

2.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

Authors:  R M Bilder; R S Goldman; D Robinson; G Reiter; L Bell; J A Bates; E Pappadopulos; D F Willson; J M Alvir; M G Woerner; S Geisler; J M Kane; J A Lieberman
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

3.  Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

Authors:  M P Hobart; R Goldberg; J J Bartko; J M Gold
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

Review 4.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

5.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

Authors:  A G Cardno; E J Marshall; B Coid; A M Macdonald; T R Ribchester; N J Davies; P Venturi; L A Jones; S W Lewis; P C Sham; I I Gottesman; A E Farmer; P McGuffin; A M Reveley; R M Murray
Journal:  Arch Gen Psychiatry       Date:  1999-02

6.  Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis.

Authors:  Margriet M Sitskoorn; André Aleman; Sjoerd J H Ebisch; Melanie C M Appels; René S Kahn
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

7.  The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

Authors:  Richard S E Keefe; Terry E Goldberg; Philip D Harvey; James M Gold; Margaret P Poe; Leigh Coughenour
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

8.  Cognitive functioning in first episode psychosis: initial presentation.

Authors:  Jean Addington; Brian L Brooks; Donald Addington
Journal:  Schizophr Res       Date:  2003-07-01       Impact factor: 4.939

9.  Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

Authors:  S Kristian Hill; Daniel Schuepbach; Ellen S Herbener; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2004-05-01       Impact factor: 4.939

10.  The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Authors:  Michael F Green; Stephen R Marder; Shirley M Glynn; Susan R McGurk; William C Wirshing; Donna A Wirshing; Robert P Liberman; Jim Mintz
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

View more
  19 in total

1.  Neural correlates of global and specific cognitive deficits in schizophrenia.

Authors:  Robert J Jirsaraie; Julia M Sheffield; Deanna M Barch
Journal:  Schizophr Res       Date:  2018-06-25       Impact factor: 4.939

2.  Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.

Authors:  William C Hochberger; Yash B Joshi; Michael L Thomas; Wendy Zhang; Andrew W Bismark; Emily B H Treichler; Melissa Tarasenko; John Nungaray; Joyce Sprock; Lauren Cardoso; Neal Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

3.  Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.

Authors:  W C Hochberger; Y B Joshi; W Zhang; M L Thomas; D L Braff; N R Swerdlow; G A Light
Journal:  Int J Psychophysiol       Date:  2018-12-23       Impact factor: 2.997

Review 4.  Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy.

Authors:  David L Braff; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2016-11-21       Impact factor: 9.306

5.  Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.

Authors:  William C Hochberger; Courtney L M Eskridge; Jeffrey R Bishop; James L Reilly; Leah H Rubin; Sarah Keedy; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Michael Ragozzino; Matcheri S Keshavan; John A Sweeney; S Kristian Hill
Journal:  Schizophr Res       Date:  2020-08-21       Impact factor: 4.939

6.  Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition.

Authors:  Julia M Sheffield; Sridhar Kandala; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; John A Sweeney; Brett A Clementz; Dov B Lerman-Sinkoff; S Kristian Hill; Deanna M Barch
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

7.  Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.

Authors:  Amanda L Rodrigue; Jennifer E McDowell; Neeraj Tandon; Matcheri S Keshavan; Carol A Tamminga; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons; Brett A Clementz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-31

8.  Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

Authors:  Milena Y Gotra; Scot K Hill; Elliot S Gershon; Carol A Tamminga; Elena I Ivleva; Godfrey D Pearlson; Matcheri S Keshavan; Brett A Clementz; Jennifer E McDowell; Peter F Buckley; John A Sweeney; Sarah K Keedy
Journal:  Schizophr Res       Date:  2020-07-14       Impact factor: 4.939

Review 9.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

10.  Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls.

Authors:  Liang-Jen Wang; Chih-Ken Chen; Shih-Ku Lin; Yi-Chih Chen; Ke Xu; Ming-Chyi Huang
Journal:  Psychopharmacology (Berl)       Date:  2018-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.